flunoxaprofen
structure given in first source
Networked: 8
relevant articles (2 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
1. | Pain (Aches)
08/31/1987
- " The results show that all variables for pain intensity greatly and progressively improved during flunoxaprofen treatment; the quality of sleep as well as the joint motion range improvement went along the progressive decrease in pain intensity. " 10/15/1987
- " The variables involving the clinical effectiveness of Flunoxaprofen, especially pain and joint motion range, assessed every two weeks showed a considerable and progressive improvement of the symptoms all along the period of treatment. " 08/31/1987
- " The patients were treated with flunoxaprofen 200-400 mg/day per os for 2 months (18 patients) or for 4 months (10 patients) and the following variables were assessed: spontaneous diurnal and nocturnal pain, pain on passive motion, pain on active motion with or without load, quality of sleep, joint motion range, intercondylar and intermalleolar straddles and gluteus-heel straddle; patients' and physician' evaluation of flunoxaprofen efficacy. " 10/31/1989
- " The results showed that flunoxaprofen and naproxen have essentially equivalent therapeutical effects in controlling painful and functional symptoms of RA: both treatments resulted in a significant relief of spontaneous diurnal and nocturnal pain, pain on active and passive motion, morning stiffness, and in a significant improvement of grip strength and Richtie's index. " 08/31/1987
- " It is concluded that flunoxaprofen may be considered an effective and safe non-steroidal antiinflammatory agent in the long-lasting management of pain and joint motility impairment of osteoarthritic patients."
|
2. | Chronic Disease (Chronic Diseases)
|
3. | Osteoarthritis
|
4. | Bacterial Vaginosis
|
5. | Vaginitis
|
|
Related Drugs and Biologics
Related Therapies and Procedures